We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nocturnal Dialysis Boosts Kidney Health

By HospiMedica International staff writers
Posted on 29 Oct 2013
Nocturnal home hemodialysis (NHD) improves kidney health as well decreasing the risk of heart disease by restoring impaired coronary endothelial responsiveness, according to a new study.

Researchers at Toronto General Hospital (TGH; Canada) examined 17 patients, which included 6 NHD patients, 6 receiving conventional intermittent hemodialysis (IHD), and five controls that required diagnostic coronary angiography (CA). More...
The IHD patients had been on dialysis for 24 months, receiving three 4-hour sessions per week, while the NHD patients received six 12-hour sessions per week. Following angiography and systemic heparin, the researchers measured drug-induced changes in mean luminal diameter (MLD), expressed as a percentage increase from baseline measurement.

The results showed that coronary endothelial responsiveness is markedly impaired in IHD patients, an effect that is partially normalized with nocturnal hemodialysis. The researchers also found that free-radical scavenging with Vitamin C partially restores endothelial function in IHD, but not NHD or control subjects, suggesting that greater oxidative stress in IHD patients may contribute to the impaired endothelial responsiveness. The study was presented at the Canadian Cardiovascular Congress, held during October 2013 in Montreal (Canada).

“Patients with end-stage renal disease have at least a five-fold increase in cardiovascular complications,” said study coauthor cardiologist Christopher Overgaard, MD. “Longer dialysis done while patients are sleeping may improve the health of arteries and could lower the risk of developing heart disease.”

When patients with accelerated atherosclerosis in end-stage renal disease (ESRD) under an IHD regimen are converted to NHD, they experience a rapid (1-2 months) increase in dialysis dose, restoring both absent brachial artery endothelium-dependent hyperemia and markedly impaired endothelium-independent vasodilatation.

Related Links:

Toronto General Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.